Tumor suppressive role of sestrin2 during colitis and colon carcinogenesis

eLife

Volumn 5, Issue FEBRUARY2016, 2016, Pages

  Ro, Seung Hyun ^a,b   Xue, Xiang ^a   Ramakrishnan, Sadeesh K ^a   Cho, Chun Seok ^a   Namkoong, Sim ^a   Jang, Insook ^a   Semple, Ian A ^a   Ho, Allison ^a   Park, Hwan Woo ^a,c   Shah, Yatrik M ^a   Lee, Jun Hee ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^c Konyang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; GLUCOSE REGULATED PROTEIN 78; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; IRINOTECAN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; PROTEIN P53; SESTRIN2 PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; NUCLEAR PROTEIN; SESN2 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY WEIGHT; CANCER INHIBITION; CELL PROLIFERATION; COLON CARCINOGENESIS; CONTROLLED STUDY; DOWN REGULATION; ENDOPLASMIC RETICULUM STRESS; GENE DOSAGE; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR VOLUME; TUNEL ASSAY; ULCERATIVE COLITIS; UPREGULATION; WESTERN BLOTTING; ANIMAL; CARCINOGENESIS; COLON; COLON TUMOR; DISEASE MODEL; METABOLISM; NEOPLASM; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; CARCINOGENESIS; COLITIS, ULCERATIVE; COLON; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; ENDOPLASMIC RETICULUM STRESS; HUMANS; MICE; NEOPLASMS; NUCLEAR PROTEINS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 84961267132     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.12204     Document Type: Article

References (60)

1. Agarwal S, Bell CM, Taylor SM, Moran RG. 2016. p53 Deletion or Hotspot Mutations Enhance mTORC1 Activity by Altering Lysosomal Dynamics of TSC2 and Rheb. Molecular Cancer Research 14:66-77. doi: 10.1158/1541-7786.MCR-15-0159
2. Anderson ER, Taylor M, Xue X, Ramakrishnan SK, Martin A, Xie L, Bredell BX, Gardenghi S, Rivella S, Shah YM. 2013. Intestinal HIF2 promotes tissue-iron accumulation in disorders of iron overload with anemia. Proceedings of the National Academy of Sciences of the United States of America 110:E4922-E4930. doi: 10.1073/pnas.1314197110
3. Bae SH, Sung SH, Oh SY, Lim JM, Lee SK, Park YN, Lee HE, Kang D, Rhee SG. 2013. Sestrins Activate Nrf2 by Promoting p62-Dependent Autophagic Degradation of Keap1 and Prevent Oxidative Liver Damage. Cell Metabolism 17:73-84. doi: 10.1016/j.cmet.2012.12.002
4. Bertolotti A, Wang X, Novoa I, Jungreis R, Schlessinger K, Cho JH, West AB, Ron D. 2001. Increased sensitivity to dextran sodium sulfate colitis in IRE1b-deficient mice. Journal of Clinical Investigation 107:585-593. doi: 10.1172/JCI11476
5. Bruning A, Rahmeh M, Friese K. 2013. Nelfinavir and bortezomib inhibit mTOR activity via ATF4-mediated sestrin-2 regulation. Molecular Oncology 7:1012-1018. doi: 10.1016/j.molonc.2013.07.010
6. Budanov AV, Karin M. 2008. p53 Target Genes Sestrin1 and Sestrin2 Connect Genotoxic Stress and mTOR Signaling. Cell 134:451-460. doi: 10.1016/j.cell.2008.06.028
7. Budanov AV, Sablina AA, Feinstein E, Koonin EV, Chumakov PM. 2004. Regeneration of Peroxiredoxins by p53- Regulated Sestrins, Homologs of Bacterial AhpD. Science 304:596-600. doi: 10.1126/science.1095569
8. Budanov AV, Shoshani T, Faerman A, Zelin E, Kamer I, Kalinski H, Gorodin S, Fishman A, Chajut A, Einat P, Skaliter R, Gudkov AV, Chumakov PM, Feinstein E. 2002. Identification of a novel stress-responsive gene Hi95 involved in regulation of cell viability. Oncogene 21:6017-6031. doi: 10.1038/sj.onc.1205877
9. Cancer Genome Atlas Network. 2012. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487:330-337. doi: 10.1038/nature11252
10. Cao SS, Zimmermann EM, Chuang B-M, Song B, Nwokoye A, Wilkinson JE, Eaton KA, Kaufman RJ. 2013. The Unfolded Protein Response and Chemical Chaperones Reduce Protein Misfolding and Colitis in Mice. Gastroenterology 144:989-1000. doi: 10.1053/j.gastro.2013.01.023
11. Chantranupong L, Wolfson RL, Orozco JM, Saxton RA, Scaria SM, Bar-Peled L, Spooner E, Isasa M, Gygi SP, Sabatini DM. 2014. The Sestrins Interact with GATOR2 to Negatively Regulate the Amino-Acid-Sensing Pathway Upstream of mTORC1. Cell Reports 9:1-8. doi: 10.1016/j.celrep.2014.09.014
12. Ding B, Parmigiani A, Yang C, Budanov AV. 2015. Sestrin2 facilitates death receptor-induced apoptosis in lung adenocarcinoma cells through regulation of XIAP degradation. Cell Cycle 14:3231-3241. doi: 10.1080/15384101.2015.1084447
13. Faller WJ, Jackson TJ, Knight JRP, Ridgway RA, Jamieson T, Karim SA, Jones C, Radulescu S, Huels DJ, Myant KB, Dudek KM, Casey HA, Scopelliti A, Cordero JB, Vidal M, Pende M, Ryazanov AG, Sonenberg N, Meyuhas O, Hall MN, Bushell M, Willis AE, Sansom OJ. 2015.mTORC1-mediated translational elongation limits intestinal tumour initiation and growth. Nature 517:497-500. doi: 10.1038/nature13896
14. Fearon ER. 2011. Molecular Genetics of Colorectal Cancer. Annual Review of Pathology: Mechanisms of Disease 6:479-507. doi: 10.1146/annurev-pathol-011110-130235
15. Feng Y, Sentani K, Wiese A, Sands E, Green M, Bommer GT, Cho KR, Fearon ER. 2013. Sox9 Induction, Ectopic Paneth Cells, and Mitotic Spindle Axis Defects in Mouse Colon Adenomatous Epithelium Arising From Conditional Biallelic Apc Inactivation. The American Journal of Pathology 183:493-503. doi: 10.1016/j.ajpath.2013.04.013
16. Feng Z, Hu W, de Stanchina E, Teresky AK, Jin S, Lowe S, Levine AJ. 2007. The Regulation of AMPK 1, TSC2, and PTEN Expression by p53: Stress, Cell and Tissue Specificity, and the Role of These Gene Products in Modulating the IGF-1-AKT-mTOR Pathways. Cancer Research 67:3043-3053. doi: 10.1158/0008-5472.CAN-06-4149
17. Feng Z, Levine AJ. 2010. The regulation of energy metabolism and the IGF-1/mTOR pathways by the p53 protein. Trends in Cell Biology 20:427-434. doi: 10.1016/j.tcb.2010.03.004
18. Fritz T, Niederreiter L, Adolph T, Blumberg RS, Kaser A. 2011. Crohn’s disease: NOD2, autophagy and ER stress converge. Gut 60:1580-1588. doi: 10.1136/gut.2009.206466
19. Gaspar C, Cardoso J, Franken P, Molenaar L, Morreau H, Moslein G, Sampson J, Boer JM, de Menezes RX, Fodde R. 2008. Cross-Species Comparison of Human and Mouse Intestinal Polyps Reveals Conserved Mechanisms in Adenomatous Polyposis Coli (APC)-Driven Tumorigenesis. The American Journal of Pathology 172:1363-1380. doi: 10.2353/ajpath.2008.070851
20. Graudens E, Boulanger V, Mollard C, Mariage-Samson R, Barlet X, Grémy G, Couillault C, Lajémi M, Piatier- Tonneau D, Zaborski P, Eveno E, Auffray C, Imbeaud S. 2006. Deciphering cellular states of innate tumor drug responses. Genome Biology 7:R19. doi: 10.1186/gb-2006-7-3-r19
21. Grivennikov SI, Wang K, Mucida D, Stewart CA, Schnabl B, Jauch D, Taniguchi K, Yu G-Y, Osterreicher CH, Hung KE, Datz C, Feng Y, Fearon ER, Oukka M, Tessarollo L, Coppola V, Yarovinsky F, Cheroutre H, Eckmann L, Trinchieri G, Karin M. 2012. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17- mediated tumour growth. Nature 491:254-258. doi: 10.1038/nature11465
22. Hardiman KM, Liu J, Feng Y, Greenson JK, Fearon ER. 2014. Rapamycin Inhibition of Polyposis and Progression to Dysplasia in a Mouse Model. PLoS ONE 9:e96023. doi: 10.1371/journal.pone.0096023
23. Hay N, Sonenberg N. 2004. Upstream and downstream of mTOR. Genes & Development 18:1926-1945. doi: 10.1101/gad.1212704
24. Hong Y, Downey T, Eu KW, Koh PK, Cheah PY. 2010. A ‘metastasis-prone’ signature for early-stage mismatch- repair proficient sporadic colorectal cancer patients and its implications for possible therapeutics. Clinical & Experimental Metastasis 27:83-90. doi: 10.1007/s10585-010-9305-4
25. Kaiser S, Park Y-K, Franklin JL, Halberg RB, Yu M, Jessen WJ, Freudenberg J, Chen X, Haigis K, Jegga AG, Kong S, Sakthivel B, Xu H, Reichling T, Azhar M, Boivin GP, Roberts RB, Bissahoyo AC, Gonzales F, Bloom GC, Eschrich S, Carter SL, Aronow JE, Kleimeyer J, Kleimeyer M, Ramaswamy V, Settle SH, Boone B, Levy S, Graff JM, Doetschman T, Groden J, Dove WF, Threadgill DW, Yeatman TJ, Coffey RJ, Aronow BJ. 2007. Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer. Genome Biology 8:R131. doi: 10.1186/gb-2007-8-7-r131
26. Kaser A, Lee A-H, Franke A, Glickman JN, Zeissig S, Tilg H, Nieuwenhuis EES, Higgins DE, Schreiber S, Glimcher LH, Blumberg RS. 2008. XBP1 Links ER Stress to Intestinal Inflammation and Confers Genetic Risk for Human Inflammatory Bowel Disease. Cell 134:743-756. doi: 10.1016/j.cell.2008.07.021
27. Kim H, An S, Ro S-H, Teixeira F, Jin Park G, Kim C, Cho C-S, Kim J-S, Jakob U, Hee Lee J, Cho U-S. 2015a. Janus-faced Sestrin2 controls ROS and mTOR signalling through two separate functional domains. Nature Communications 6:10025. doi: 10.1038/ncomms10025
28. Kim JS, Ro S-H, Kim M, Park H-W, Semple IA, Park H, Cho U-S, Wang W, Guan K-L, Karin M, Lee JH. 2015b. Sestrin2 inhibits mTORC1 through modulation of GATOR complexes. Scientific Reports 5:9502. doi: 10.1038/srep09502
29. Lee JH, Budanov AV, Karin M. 2013. Sestrins Orchestrate Cellular Metabolism to Attenuate Aging. Cell Metabolism 18:792-801. doi: 10.1016/j.cmet.2013.08.018
30. Lee JH, Budanov AV, Park EJ, Birse R, Kim TE, Perkins GA, Ocorr K, Ellisman MH, Bodmer R, Bier E, Karin M. 2010. Sestrin as a Feedback Inhibitor of TOR That Prevents Age-Related Pathologies. Science 327:1223-1228. doi: 10.1126/science.1182228
31. Lee JH, Budanov AV, Talukdar S, Park EJ, Park HL, Park H-W, Bandyopadhyay G, Li N, Aghajan M, Jang I, Wolfe AM, Perkins GA, Ellisman MH, Bier E, Scadeng M, Foretz M, Viollet B, Olefsky J, Karin M. 2012. Maintenance of Metabolic Homeostasis by Sestrin2 and Sestrin3. Cell Metabolism 16:311-321. doi: 10.1016/j.cmet.2012.08.004
32. Nambiar PR, Nakanishi M, Gupta R, Cheung E, Firouzi A, Ma XJ, Flynn C, Dong M, Guda K, Levine J, Raja R, Achenie L, Rosenberg DW. 2004. Genetic signatures of High- and Low-Risk Aberrant Crypt Foci in a Mouse Model of Sporadic Colon Cancer. Cancer Research 64:6394-6401. doi: 10.1158/0008-5472.CAN-04-0933
33. Nogueira V, Park Y, Chen C-C, Xu P-Z, Chen M-L, Tonic I, Unterman T, Hay N. 2008. Akt Determines Replicative Senescence and Oxidative or Oncogenic Premature Senescence and Sensitizes Cells to Oxidative Apoptosis. Cancer Cell 14:458-470. doi: 10.1016/j.ccr.2008.11.003
34. Ozcan U, Ozcan L, Yilmaz E, Duvel K, Sahin M, Manning BD, Hotamisligil GS. 2008. Loss of the Tuberous Sclerosis Complex Tumor Suppressors Triggers the Unfolded Protein Response to Regulate Insulin Signaling and Apoptosis. Molecular Cell 29:541-551. doi: 10.1016/j.molcel.2007.12.023
35. Park EJ, Lee JH, Yu G-Y, He G, Ali SR, Holzer RG, Osterreicher CH, Takahashi H, Karin M. 2010. Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression. Cell 140:197-208. doi: 10.1016/j.cell.2009.12.052
36. Park H-W, Park H, Ro S-H, Jang I, Semple IA, Kim DN, Kim M, Nam M, Zhang D, Yin L, Lee JH. 2014. Hepatoprotective role of Sestrin2 against chronic ER stress. Nature Communications 5:4233. doi: 10.1038/ncomms5233
37. Parmigiani A, Nourbakhsh A, Ding B, Wang W, Kim YC, Akopiants K, Guan K-L, Karin M, Budanov AV. 2014. Sestrins Inhibit mTORC1 Kinase Activation through the GATOR Complex. Cell Reports 9:1281-1291. doi: 10. 1016/j.celrep.2014.10.019
38. Peng M, Yin N, Li MO. 2014. Sestrins Function as Guanine Nucleotide Dissociation Inhibitors for Rag GTPases to Control mTORC1 Signaling. Cell 159:122-133. doi: 10.1016/j.cell.2014.08.038
39. Rhodes DR, Kalyana-Sundaram S, Mahavisno V, Varambally R, Yu J, Briggs BB, Barrette TR, Anstet MJ, Kincead- Beal C, Kulkarni P, Varambally S, Ghosh D, Chinnaiyan AM. 2007. Oncomine 3.0: Genes, Pathways, and Networks in a Collection of 18,000 Cancer Gene Expression Profiles. Neoplasia 9:166-180. doi: 10.1593/neo.07112
40. Riley T, Sontag E, Chen P, Levine A. 2008. Transcriptional control of human p53-regulated genes. Nature Reviews Molecular Cell Biology 9:402-412. doi: 10.1038/nrm2395
41. Ro S-H, Nam M, Jang I, Park H-W, Park H, Semple IA, Kim M, Kim JS, Park H, Einat P, Damari G, Golikov M, Feinstein E, Lee JH. 2014a. Sestrin2 inhibits uncoupling protein 1 expression through suppressing reactive oxygen species. Proceedings of the National Academy of Sciences of the United States of America 111:7849-7854. doi: 10.1073/pnas.1401787111
42. Ro S-H, Semple IA, Park H, Park H, Park H-W, Kim M, Kim JS, Lee JH. 2014b. Sestrin2 promotes Unc-51-like kinase 1 mediated phosphorylation of p62/sequestosome-1. FEBS Journal 281:3816-3827. doi: 10.1111/febs.12905
43. Rosenberg DW, Giardina C, Tanaka T. 2009. Mouse models for the study of colon carcinogenesis. Carcinogenesis 30:183-196. doi: 10.1093/carcin/bgn267
44. Sablina AA, Budanov AV, Ilyinskaya GV, Agapova LS, Kravchenko JE, Chumakov PM. 2005. The antioxidant function of the p53 tumor suppressor. Nature Medicine 11:1306-1313. doi: 10.1038/nm1320
45. Sanli T, Linher-Melville K, Tsakiridis T, Singh G. 2012. Sestrin2 Modulates AMPK Subunit Expression and Its Response to Ionizing Radiation in Breast Cancer Cells. PLoS ONE 7:e32035. doi: 10.1371/journal.pone.0032035
46. Siegel RL, Miller KD, Jemal A. 2015. Cancer statistics, 2015. CA: A Cancer Journal for Clinicians 65:5-29. doi: 10. 3322/caac.21254
47. Skrzypczak M, Goryca K, Rubel T, Paziewska A, Mikula M, Jarosz D, Pachlewski J, Oledzki J, Ostrowski J, Ostrowsk J. 2010. Correction: Modeling Oncogenic Signaling in Colon Tumors by Multidirectional Analyses of Microarray Data Directed for Maximization of Analytical Reliability. PLoS ONE 5. doi: 10.1371/annotation/8c585739-a354-4fc9-a7d0-d5ae26fa06ca
48. Takahashi M, Wakabayashi K. 2004. Gene mutations and altered gene expression in azoxymethane-induced colon carcinogenesis in rodents. Cancer Science 95:475-480. doi: 10.1111/j.1349-7006.2004.tb03235.x
49. Terzic´ J, Grivennikov S, Karin E, Karin M. 2010. Inflammation and Colon Cancer. Gastroenterology 138:2101-2114. doi: 10.1053/j.gastro.2010.01.058
50. Thiem S, Pierce TP, Palmieri M, Putoczki TL, Buchert M, Preaudet A, Farid RO, Love C, Catimel B, Lei Z, Rozen S, Gopalakrishnan V, Schaper F, Hallek M, Boussioutas A, Tan P, Jarnicki A, Ernst M. 2013. mTORC1 inhibition restricts inflammation-associated gastrointestinal tumorigenesis in mice. Journal of Clinical Investigation 123: 767-781. doi: 10.1172/JCI65086
51. Thorsteinsdottir S, Gudjonsson T, Nielsen OH, Vainer B, Seidelin JB. 2011. Pathogenesis and biomarkers of carcinogenesis in ulcerative colitis. Nature Reviews Gastroenterology & Hepatology 8:395-404. doi: 10.1038/nrgastro.2011.96
52. Velasco-Miguel S, Buckbinder L, Jean P, Gelbert L, Talbott R, Laidlaw J, Seizinger B, Kley N. 1999. PA26, a novel target of the p53 tumor suppressor and member of the GADD family of DNA damage and growth arrest inducible genes. Oncogene 18:127-137. doi: 10.1038/sj.onc.1202274
53. Wang M, Kaufman RJ. 2014. The impact of the endoplasmic reticulum protein-folding environment on cancer development. Nature Reviews Cancer 14:581-597. doi: 10.1038/nrc3800
54. Wolfson RL, Chantranupong L, Saxton RA, Shen K, Scaria SM, Cantor JR, Sabatini DM. 2016. Sestrin2 is a leucine sensor for the mTORC1 pathway. Science 351:43-48. doi: 10.1126/science.aab2674
55. Woo HA, Bae SH, Park S, Rhee SG. 2009. Sestrin 2 Is Not a Reductase for Cysteine Sulfinic Acid of Peroxiredoxins. Antioxidants & Redox Signaling 11:739-745. doi: 10.1089/ars.2008.2360
56. Xue X, Ramakrishnan S, Anderson E, Taylor M, Zimmermann EM, Spence JR, Huang S, Greenson JK, Shah YM. 2013. Endothelial PAS Domain Protein 1 Activates the Inflammatory Response in the Intestinal Epithelium to Promote Colitis in Mice. Gastroenterology 145:831-841. doi: 10.1053/j.gastro.2013.07.010
57. Ye J, Palm W, Peng M, King B, Lindsten T, Li MO, Koumenis C, Thompson CB. 2015. GCN2 sustains mTORC1 suppression upon amino acid deprivation by inducing Sestrin2. Genes & Development 29:2331-2336. doi: 10. 1101/gad.269324.115
58. Young RM, Ackerman D, Quinn ZL, Mancuso A, Gruber M, Liu L, Giannoukos DN, Bobrovnikova-Marjon E, Diehl JA, Keith B, Simon MC. 2013. Dysregulated mTORC1 renders cells critically dependent on desaturated lipids for survival under tumor-like stress. Genes & Development 27:1115-1131. doi: 10.1101/gad.198630.112
59. Zhu H, Li YR. 2012. Oxidative stress and redox signaling mechanisms of inflammatory bowel disease: updated experimental and clinical evidence. Experimental Biology and Medicine 237:474-480. doi: 10.1258/ebm.2011.011358
60. Zoncu R, Efeyan A, Sabatini DM. 2011. mTOR: from growth signal integration to cancer, diabetes and ageing. Nature Reviews Molecular Cell Biology 12:21-35. doi: 10.1038/nrm3025